Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus

INTRODUCTION/AIM: Insulin degludec/insulin aspart (IDegAsp) is a soluble co-formulation of long-acting and short-acting insulin analogs. The primary objective of this study was to investigate the pharmacodynamic response of once-daily IDegAsp dosing in patients with type 1 diabetes. Pharmacokinetic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Heise, Tim, Nosek, Leszek, Roepstorff, Carsten, Chenji, Suresh, Klein, Oliver, Haahr, Hanne
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065302/
https://ncbi.nlm.nih.gov/pubmed/24888255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0070-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi